Shannon Thyme Klinger Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 hours ago
Shannon Thyme Klinger has an estimated net worth of at least $15.2 million*, as of today. They own 79,266 shares of MRNA stock. They have sold 34,945 shares of MRNA stock since 2021, for an estimated $3.0 million.
Shannon Thyme Klinger $MRNA SEC Form 4 Insider Trading
Shannon Thyme Klinger has filed a total of 27 insider trades in $MRNA since 2021. Their most recent trade was a sale of 3,471 shares, made on Jun 04, 2026. Their largest trade was a sale of 13,885 shares, made on Mar 02, 2026. We estimate that they now own 79,266 shares of $MRNA, worth an estimated $12.2 million.
Insider Trading at $MRNA
There have been a total of 1451 insider trades reported at $MRNA since 2021, with 191,934 shares purchased and 9.6 million shares sold. The most active insider traders in $MRNA stock have been Stephane Bancel, Stephen Hoge, and Juan Andres. The most recent trade was a sale of 39,891 shares reported by Stephane Bancel (Chief Executive Officer), made on Aug 05, 2026.
History of Insider Stock Trades by Shannon Thyme Klinger
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
MRNA
|
Sale | 3,471 | Jun 04, 2026 | June 8, 2026, 4:34 p.m. |
|
MRNA
|
Sale | 13,885 | Mar 02, 2026 | March 3, 2026, 5:10 p.m. |
|
MRNA
|
Sale | 529 | Dec 09, 2024 | Dec. 10, 2024, 5:08 p.m. |
|
MRNA
|
Sale | 112 | Dec 03, 2024 | Dec. 4, 2024, 6:11 p.m. |
|
MRNA
|
Sale | 1,418 | Nov 29, 2024 | Dec. 2, 2024, 5:19 p.m. |
|
MRNA
|
Sale | 551 | Sep 09, 2024 | Sept. 10, 2024, 4:15 p.m. |
|
MRNA
|
Sale | 114 | Sep 03, 2024 | Sept. 4, 2024, 5:42 p.m. |
|
MRNA
|
Sale | 162 | Aug 29, 2024 | Aug. 30, 2024, 4:34 p.m. |
|
MRNA
|
Sale | 1,319 | Aug 28, 2024 | Aug. 29, 2024, 4:03 p.m. |
|
MRNA
|
Sale | 5,178 | Jun 10, 2024 | June 11, 2024, 4:05 p.m. |
|
MRNA
|
Sale | 122 | Jun 03, 2024 | June 4, 2024, 5:12 p.m. |
|
MRNA
|
Sale | 183 | May 29, 2024 | May 30, 2024, 4:27 p.m. |
|
MRNA
|
Sale | 1,296 | May 28, 2024 | May 29, 2024, 4:12 p.m. |
|
MRNA
|
Sale | 544 | Mar 08, 2024 | March 11, 2024, 9:05 a.m. |
|
MRNA
|
Sale | 117 | Mar 04, 2024 | March 5, 2024, 6:56 p.m. |
|
MRNA
|
Sale | 670 | Feb 29, 2024 | March 1, 2024, 6:29 p.m. |
|
MRNA
|
Sale | 563 | Dec 08, 2023 | Dec. 11, 2023, 5:03 p.m. |
|
MRNA
|
Sale | 111 | Dec 04, 2023 | Dec. 5, 2023, 5:10 p.m. |
|
MRNA
|
Sale | 557 | Sep 08, 2023 | Sept. 11, 2023, 4:02 p.m. |
|
MRNA
|
Sale | 115 | Sep 05, 2023 | Sept. 6, 2023, 4:17 p.m. |
|
MRNA
|
Sale | 565 | Jun 08, 2023 | June 9, 2023, 4:09 p.m. |
|
MRNA
|
Sale | 110 | Jun 02, 2023 | June 5, 2023, 4:20 p.m. |
|
MRNA
|
Sale | 561 | Mar 08, 2023 | March 9, 2023, 5:13 p.m. |
|
MRNA
|
Sale | 459 | Mar 02, 2023 | March 3, 2023, 5:21 p.m. |
|
MRNA
|
Sale | 490 | Dec 08, 2022 | Dec. 9, 2022, 5:07 p.m. |
|
MRNA
|
Sale | 478 | Sep 08, 2022 | Sept. 9, 2022, 4:17 p.m. |
|
MRNA
|
Sale | 1,265 | Jun 08, 2022 | June 9, 2022, 4:14 p.m. |
$MRNA Executives and Stock Owners with Insider Trades
-
Stephane Bancel, Chief Executive Officer
-
Stephen Hoge, President
-
Juan Andres, See remarks
-
Shannon Thyme Klinger, Chief Legal Officer
-
James M Mock, Chief Financial Officer
-
Tal Zvi Zaks, Chief Medical Officer
-
Arpa Garay, Chief Commercial Officer
-
David W Meline, Chief Financial Officer
-
Paul Burton, Chief Medical Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.